Name
osaühing FAVOREK PEREARSTIKESKUS
Registry code
10813709
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
13.11.2001 (23)
Financial year
01.01-31.12
Capital
2 700.00 €
Activity
86211 - Provision of general medical treatment
45 208 €
251 672 €
557%
1 983 €
(estimate is approximate)
348 029 €
15
Submitted
No tax arrears
72%
57%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Anastasia Kudryashova 11.08.1988 (36) | 29% - 791.00 EUR | - | Direct ownership | |
| Helena Grauberg 10.12.1986 (37) | 2% - 50.00 EUR | - | - | |
| Alla Rušai 19.01.1988 (36) | 16% - 442.00 EUR | - | - | |
| Anne Reiman 07.05.1967 (57) | 52% - 1 417.00 EUR | Board member | Direct ownership | |
| Märt Rõngelep 08.10.1963 (61) | - | Board member | - |
| 2019 04.03.2020 | 2020 18.03.2021 | 2021 17.03.2022 | 2022 05.03.2023 | 2023 03.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 62 910 € | 36 583 € | 43 987 € | 33 889 € | 45 208 € |
| Net profit (loss) for the period | 118 495 € | 113 492 € | 184 050 € | 155 585 € | 251 672 € |
| Profit Margin | 188% | 310% | 418% | 459% | 557% |
| Current Assets | 223 985 € | 262 474 € | 327 150 € | 297 664 € | 417 642 € |
| Fixed Assets | - | - | - | 26 990 € | 20 990 € |
| Total Assets | 223 985 € | 262 474 € | 327 150 € | 324 654 € | 438 632 € |
| Current Liabilities | 42 762 € | 59 759 € | 63 516 € | 59 325 € | 76 147 € |
| Non Current Liabilities | - | - | - | 19 754 € | 14 456 € |
| Total Liabilities | - | - | - | 79 079 € | 90 603 € |
| Share Capital | - | - | - | - | - |
| Equity | 181 223 € | 202 715 € | 263 634 € | 245 575 € | 348 029 € |
| Employees | 13 | 14 | 15 | 14 | 15 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 69 104.34 € | 54 412.26 € | 15 |
| 2023 Q4 | - | 55 602.3 € | 59 582.26 € | 15 |
| 2023 Q3 | - | 56 757.77 € | 50 032.64 € | 14 |
| 2023 Q2 | - | 60 137.8 € | 46 596.78 € | 14 |
| 2023 Q1 | - | 41 564.31 € | 44 303.68 € | 14 |
| 2022 Q4 | - | 50 829.9 € | 43 922.62 € | 13 |
| 2022 Q3 | - | 47 607.54 € | 37 425.39 € | 13 |
| 2022 Q2 | - | 57 427.78 € | 53 780.18 € | 16 |
| 2022 Q1 | - | 52 564.61 € | 49 797.49 € | 14 |
| 2021 Q4 | - | 35 334.06 € | 37 530.99 € | 13 |
| 2021 Q3 | - | 40 301.87 € | 43 391.1 € | 13 |
| 2021 Q2 | - | 52 183.16 € | 41 010.23 € | 14 |
| 2021 Q1 | - | 56 179.92 € | 49 097.61 € | 14 |
| 2020 Q4 | - | 36 065.19 € | 38 843.29 € | 14 |
| 2020 Q3 | - | 36 502.76 € | 39 290.45 € | 13 |
| 2020 Q2 | - | 31 755 € | 34 124.16 € | 13 |
| 2020 Q1 | - | 58 793.59 € | 42 278.9 € | 12 |
